3

PRIMARY DOCUMENT

Company: ALNYLAM PHARMACEUTICALS, INC.
Filed: February 13, 2008
Period of Report: February 11, 2008
Accession Number: 0001325812-08-000010

View Document ↗ View on SEC.gov ↗